Last reviewed · How we verify

NCT05262374: VOLTAIRE

Versius or Laparoscopic TransAbdominal Inguinal Hernia REpair

Completed Last updated 12 March 2025
What this trial tests

trial testing Procedure/Surgery: Laparoscopic in Inguinal Hernia in 60 participants. Completed in 5 April 2024.

Timeline
9 February 2023
Primary endpoint
5 April 2024
5 April 2024

Quick facts

Lead sponsorMilton Keynes University Hospital NHS Foundation Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date9 February 2023
Primary completion5 April 2024
Estimated completion5 April 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Milton Keynes University Hospital NHS Foundation Trust

Who can join

Adults 18 to 100, any sex, with Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial will compare laparoscopic and robotic-assisted inguinal hernia repairs, using the Versius® system. We will initially aim to recruit 60 patients (20 patients in the laparoscopic arm and 40 in the robotic arm) in order to assess the ergonomic impact of each modality on the operating surgeon. This aims to provide in vivo information on whether robotic surgery provides any advantages to the operating surgeon. This trial will also be used to assess the feasibility of recruitment to a future larger study, and any data collected will be used as pilot data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inguinal Hernia

Currently open trials in the same condition.

Other Milton Keynes University Hospital NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05262374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing